gastric tumor, colon tumor
Conditions
Interventions
5-aminolevulinic acid(5-ALA) 20mg/kg peroral administration once
Sponsors
Yamaguchi university graduate school of medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who were referred to the hospital for treatment for stomach and colorectal tumors scheduled endoscopic resection
Exclusion criteria
Exclusion criteria: Patients with liver dysfunction Hypersensitivity to porphyrins
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fluorescence intesity and distrbution in the tumors | — |
Countries
Japan
Contacts
Public ContactJun Nishikawa
Yamaguchi university graduate school of medicine Department of gastroenterology and hepatology
Outcome results
None listed